SECOND EDITION Pharmaceutical Preformulation And Formulation

Transcription

DRUGS AND THE PHARMACEUTICAL SCIENCESVOLUME 199SECOND EDITIONPharmaceuticalPreformulation andFormulationA Practical Guide from Candidate Drug Selection to Commercial Dosage Formedited byMark Gibson

PharmaceuticalPreformulation andFormulation

DRUGS AND THE PHARMACEUTICAL SCIENCESA Series of Textbooks and MonographsExecutive EditorJames SwarbrickPharmaceuTech, Inc.Pinehurst, North CarolinaAdvisory BoardLarry L. AugsburgerUniversity of MarylandBaltimore, MarylandJennifer B. DressmanUniversity of Frankfurt Instituteof Pharmaceutical TechnologyFrankfurt, GermanyAnthony J. HickeyUniversity of North CarolinaSchool of PharmacyChapel Hill, North CarolinaAjaz HussainSandozPrinceton, New JerseyJoseph W. PolliGlaxoSmithKlineResearch Triangle ParkNorth CarolinaStephen G. SchulmanHarry G. BrittainCenter for Pharmaceutical Physics Milford,New JerseyRobert GurnyUniversite de GeneveGeneve, SwitzerlandJeffrey A. HughesUniversity of Florida Collegeof PharmacyGainesville, FloridaVincent H. L. LeeUS FDA Center for DrugEvaluation and ResearchLos Angeles, CaliforniaKinam ParkPurdue UniversityWest Lafayette, IndianaJerome P. SkellyAlexandria, VirginiaUniversity of FloridaGainesville, FloridaElizabeth M. ToppYuichi SugiyamaUniversity of KansasLawrence, KansasUniversity of Tokyo, Tokyo, JapanGeoffrey T. TuckerUniversity of SheffieldRoyal Hallamshire HospitalSheffield, United KingdomPeter YorkUniversity of BradfordSchool of PharmacyBradford, United Kingdom

For information on volumes 1–149 in the Drugs and PharmaceuticalScience Series, please visit www.informahealthcare.com150. Laboratory Auditing for Quality and Regulatory Compliance, Donald Singer,Raluca-Ioana Stefan, and Jacobus van Staden151. Active Pharmaceutical Ingredients: Development, Manufacturing, and Regulation,edited by Stanley Nusim152. Preclinical Drug Development, edited by Mark C. Rogge and David R. Taft153. Pharmaceutical Stress Testing: Predicting Drug Degradation, edited bySteven W. Baertschi154. Handbook of Pharmaceutical Granulation Technology: Second Edition,edited by Dilip M. Parikh155. Percutaneous Absorption: h Edition, edited by Robert L. Bronaugh and Howard I. Maibach156. Pharmacogenomics: Second Edition, edited by Werner Kalow, Urs A. Meyerand Rachel F. Tyndale157. Pharmaceutical Process Scale-Up, Second Edition, edited by Michael Levin158. Microencapsulation: Methods and Industrial Applications, Second Edition,edited by Simon Benita159. Nanoparticle Technology for Drug Delivery, edited by Ram B. Gupta andUday B. Kompella160. Spectroscopy of Pharmaceutical Solids, edited by Harry G. Brittain161. Dose Optimization in Drug Development, edited by Rajesh Krishna162. Herbal Supplements-Drug Interactions: Scientific and Regulatory Perspectives,edited by Y. W. Francis Lam, Shiew-Mei Huang, and Stephen D. Hall163. Pharmaceutical Photostability and Stabilization Technology, edited byJoseph T. Piechocki and Karl Thoma164. Environmental Monitoring for Cleanrooms and Controlled Environments,edited by Anne Marie Dixon165. Pharmaceutical Product Development: In Vitro-In Vivo Correlation, edited byDakshina Murthy Chilukuri, Gangadhar Sunkara, and David Young166. Nanoparticulate Drug Delivery Systems, edited by Deepak Thassu, MichelDeleers, and Yashwant Pathak167. Endotoxins: Pyrogens, LAL Testing and Depyrogenation, Third Edition,edited by Kevin L. Williams168. Good Laboratory Practice Regulations, Fourth Edition, edited by AnneSandy Weinberg169. Good Manufacturing Practices for Pharmaceuticals, Sixth Edition,edited by Joseph D. Nally170. Oral-Lipid Based Formulations: Enhancing the Bioavailability of PoorlyWater-soluble Drugs, edited by David J. Hauss171. Handbook of Bioequivalence Testing, edited by Sarfaraz K. Niazi172. Advanced Drug Formulation Design to Optimize Therapeutic Outcomes,edited by Robert O. Williams III, David R. Taft, and Jason T. McConville173. Clean-in-Place for Biopharmaceutical Processes, edited by DaleA. Seiberling174. Filtration and Purification in the Biopharmaceutical Industry, Second Edition,edited by Maik W. Jornitz and Theodore H. Meltzer175. Protein Formulation and Delivery, Second Edition, edited by EugeneJ. McNally and Jayne E. Hastedt

176. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, ThirdEdition, edited by James McGinity and Linda A. Felton177. Dermal Absorption and Toxicity Assessment, Second Edition, edited byMichael S. Roberts and Kenneth A. Walters178. Preformulation Solid Dosage Form Development, edited by Moji C. Adeyeyeand Harry G. Brittain179. Drug-Drug Interactions, Second Edition, edited by A. David Rodrigues180. Generic Drug Product Development: Bioequivalence Issues, edited byIsadore Kanfer and Leon Shargel181. Pharmaceutical Pre-Approval Inspections: A Guide to Regulatory Success,Second Edition, edited by Martin D. Hynes III182. Pharmaceutical Project Management, Second Edition, edited byAnthony Kennedy183. Modified Release Drug Delivery Technology, Second Edition, Volume 1,edited by Michael J. Rathbone, Jonathan Hadgraft, Michael S. Roberts,and Majella E. Lane184. Modified-Release Drug Delivery Technology, Second Edition, Volume 2,edited by Michael J. Rathbone, Jonathan Hadgraft, Michael S. Roberts, andMajella E. Lane185. The Pharmaceutical Regulatory Process, Second Edition, edited byIra R. Berry and Robert P. Martin186. Handbook of Drug Metabolism, Second Edition, edited by Paul G. Pearson andLarry C. Wienkers187. Preclinical Drug Development, Second Edition, edited by Mark Rogge andDavid R. Taft188. Modern Pharmaceutics, Fifth Edition, Volume 1: Basic Principles and Systems,edited by Alexander T. Florence and Juergen Siepmann189. Modern Pharmaceutics, Fifth Edition, Volume 2: Applications and Advances,edited by Alexander T. Florence and Juergen Siepmann190. New Drug Approval Process, Fifth Edition, edited by Richard A.Guarino191. Drug Delivery Nanoparticulate Formulation and Characterization, edited byYashwant Pathak and Deepak Thassu192. Polymorphism of Pharmaceutical Solids, Second Edition, edited by Harry G. Brittain193. Oral Drug Absorption: Prediction and Assessment, Second Edition, edited byJennifer J. Dressman, hans Lennernas, and Christos Reppas194. Biodrug Delivery Systems: Fundamentals, Applications, and Clinical Development,edited by Mariko Morista and Kinam Park195. Pharmaceutical Process Engineering, Second Edition, edited by Anthony J. Hickeyand David Ganderton196. Handbook of Drug Screening, Second Edition, edited by Ramakrishna Seethala andLitao Zhang197. Pharmaceutical Powder Compaction Technology, Second Edition, edited byMetin Celik198. Handbook of Pharmaceutical Granulation Technology, Dilip M. Parikh199. Pharmaceutical Preformulation and Formulation: A Practical Guide from CandidateDrug Selection to Commercial Dosage Form, Second Edition, edited byMark Gibson

PharmaceuticalPreformulation andFormulationSecond EditionA Practical Guide from Candidate Drug Selection to Commercial Dosage Formedited byMark GibsonAstraZeneca R&D CharnwoodLoughborough, Leicestershire, UK

Informa Healthcare USA, Inc.52 Vanderbilt AvenueNew York, NY 10017# 2009 by Informa Healthcare USA, Inc.Informa Healthcare is an Informa businessNo claim to original U.S. Government worksPrinted in the United States of America on acid-free paper10 9 8 7 6 5 4 3 2 1International Standard Book Number-10: 1-4200-7317-6 (Hardcover)International Standard Book Number-13: 978-1-4200-7317-1 (Hardcover)This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted withpermission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publishreliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materialsor for the consequence of their use.No part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, orother means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any informationstorage or retrieval system, without written permission from the publishers.For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC) 222 Rosewood Drive, Danvers, MA 01923,978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. Fororganizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged.Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only foridentification and explanation without intent to infringe.Library of Congress Cataloging-in-Publication DataPharmaceutical preformulation and formulation: A practical guide from candidate drugselection to commercial dosage form / edited by Mark Gibson.—2nd ed.p. ; cm. — (Drugs and the pharmaceutical sciences ; 199)Includes bibliographical references and index.ISBN-13: 978-1-4200-7317-1 (hb : alk. paper)ISBN-10: 1-4200-7317-6 (hb : alk. paper) 1. Drugs—Dosage forms.I. Gibson, Mark, 1957- II. Series: Drugs and the pharmaceuticalsciences ; v. 199.[DNLM: 1. Drug Compounding. 2. Biopharmaceutics—methods. 3.Dosage Forms. 4. Drug Discovery. 5. Drug Evaluation. W1 DR893B v.1992009 / QV 778 P53535 2009]RS200.P425 20096150 .1—dc222009012458For Corporate Sales and Reprint Permissions call 212-520-2700 or write to: Sales Department, 52 Vanderbilt Avenue,16th floor, New York, NY 10017.Visit the Informa Web site atwww.informa.comand the Informa Healthcare Web site atwww.informahealthcare.com

PrefaceThe first edition of this book published in 2001 has been more successful than I ever imagined,as indicated by the excellent reviews it has received, the continued demand, and impressivesales! I believe that the main reasons for its popularity are that there was a significant gap inthe literature and also that the information presented was based on the extensive experiencesof the various contributors who were all actively working in the industry and were willing toshare “best practice” from their knowledge and experiences. The book is intended to be apractical guide to pharmaceutical preformulation and formulation to be used as a referencesource or a guidance tool to those working in the pharmaceutical industry or relatedindustries, such as biopharmaceuticals or medical devices, or anyone wanting an insight intothe subject area. Indeed, this book has also proved to be a valuable text for undergraduate andpostgraduate courses in industrial pharmacy and pharmaceutical technology. A second editionis required because preformulation and formulation technology continues to develop and alsobecause there are bound to be some gaps and improvements to be filled.The second edition still meets the main objectives of the first edition, that is, tolllprovide a logical and structured approach to product development, with key stagesidentified and the preformulation, biopharmaceutics, and formulation activities andtypical issues at each stage discussed, wherever possible with real or worked examples,emphasize what practical studies need to be undertaken for what reasons and duringwhat key stages of the drug development process, andprovide separate chapters on the formulation development of each route and type ofdosage forms.The pressure to accelerate the drug development process, shorten the development timelines,and launch new pharmaceutical products is even more intense than before, with fewerregistrations year on year. Having a structured approach and doing the right things first timeare essential elements for achieving this. The chapters on product design and productoptimization are still very relevant but have been updated to include the quality by design(QbD) and International Conference on Harmonisation (ICH) Q8 (product development),ICH Q9 (quality risk management), process analytical technology (PAT), and leanmanufacturing principles that aim to link regulatory expectations to good science.Another significant change since the first edition is the growth of biopharmaceuticals,compared with small molecules, that deserves more attention. Pharmaceutical companies areshifting from developing small molecules to developing biopharmaceuticals to treat a widerange of diseases, and today approximately one in four drugs introduced to the market is abiopharmaceutical. Since the majority of biopharmaceuticals will be delivered by injection orinfusion, the chapter on parenteral dosage forms has been updated to reflect this. Focus hasbeen given to the steps after purification, formulation, and subsequent fill-finish. Consideration has also been given in the other chapters for handling and developing biopharmaceuticaldosage forms where there is some potential for drug delivery, for example, intranasal dosageforms.Elsewhere in the second edition, there are updates throughout the book to reflect onsome omissions and developments since the first edition and make it up-to-date; for example,to reflect emerging “cutting-edge” technologies such as polymorph and salt selection and

viiiPrefaceprediction, molecular modeling and automation in preformulation studies, and more consideration for packaging technology during development of the various dosage forms.Once again I am indebted to all the contributors for giving up their time and energy inproducing this updated version. I am also indebted to my wife, Alison, and my family for theirsupport and understanding during the time I have been busy working on this book.Mark Gibson

ContentsPrefaceContributorsviixi1. Introduction and PerspectiveMark Gibson12. Aiding Candidate Drug Selection: Introduction and ObjectivesMark Gibson113. Preformulation Investigations using Small Amounts of Compound as an Aid toCandidate D

Pharmaceutical Project Management, Second Edition, edited by Anthony Kennedy 183. Modified Release Drug Delivery Technology, Second Edition, Volume 1, edited by Michael J. Rathbone, Jonathan Hadgraft, Michael S. Roberts, and Majella E. Lane 184. Modified-Release Drug Delivery Technology, Second Edition, Volume 2, edited by Michael J. Rathbone, Jonathan Hadgraft, Michael S. Roberts,